Icon

RYALTRIS (nda211746)- (0.025MG/SPRAY;0.665MG/SPRAY)

MOMETASONE FUROATE; OLOPATADINE HYDROCHLORIDE GLENMARK SPECLT
0.025MG/SPRAY;0.665MG/SPRAY
No Yes
2038-Sep-03 Expired
None 2025-Jan-13
None No
RYALTRIS is a combination of olopatadine, a histamine-1 (H1)receptor inhibitor, and mometasone furoate, a corticosteroid, indicated for the treatment of symptoms of seasonal allergic rhinitis in adult and pediatric patients 12 years of age and older.
0 0 0
Total Other Developers 3
Drugs with Suitability No
0.025MG/SPRAY;0.665MG/SPRAY ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.